/
Patricia M. Barrett, MSD Patricia M. Barrett, MSD

Patricia M. Barrett, MSD - PowerPoint Presentation

HotMess
HotMess . @HotMess
Follow
350 views
Uploaded On 2022-07-28

Patricia M. Barrett, MSD - PPT Presentation

Antimicrobial Resistance Coordinator Antimicrobial Stewardship Collaborative New Jersey Hospital Association July 25 2018 Updates on Stewardship and Resistance Infrastructure Response Various Roles of Public Health ID: 930112

cdc stewardship testing resistance stewardship cdc resistance testing www antibiotic resources health care njdoh water lab 2018 gov resistant

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Patricia M. Barrett, MSD" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Patricia M. Barrett, MSDAntimicrobial Resistance CoordinatorAntimicrobial Stewardship CollaborativeNew Jersey Hospital AssociationJuly 25, 2018

Updates on Stewardship and Resistance

Slide2

Infrastructure

Response

Various Roles of Public Health

Slide3

Slide4

Promote best practices to prevent drug resistance and transmission

Prevention

Slide5

Introductory resources for long-term care facilities developing their stewardship programBound copy of the CDC Core Elements of Antibiotic Stewardship for Nursing HomesExample stewardship policySlide deck for staff educationCommunications strategies for providers

Patient factsheets on antibiotics and common infections

Physical and digital copies available soon

Long-term Care Stewardship Toolkit

Slide6

New program under development to recognize facility stewardship programs

Feature on the NJDOH HAI webpage

Digital media kit for each ASP

Focus-group scheduled on August 28, 2018

Determine program requirements

Incentives and benefits for enrollment

Email patricia.barrett@doh.nj.gov for more information or to join focus group

Stewardship Recognition Program

Slide7

U.S. and World Antibiotic Awareness Week is November 12-18, 2018CDC resources and updates available at: www.cdc.gov/antibiotic-use/week/index.htmlPlease share your activities and ideas for the week with NJDOH!

Reminder: Antibiotic Awareness Week

Slide8

Guide includes:Understanding your roleInternal, external, and state partnersPolicies and proceduresData and surveillanceUnderstanding your IT needs

Reportable communicable diseases

HAI prevention

Professional development

Will soon be posted on the NJDOH HAI WebsiteNew IP Guide and Resources

Slide9

CDC stewardship training available at: www.train.org/cdctrain/course/1075730

Four online modules released throughout 2018

Free registration with 8 contact hours

Clinicians

Physician AssistantsNurses

Health EducatorsPharmacistsPublic Health Practitioners

CDC Antibiotic Stewardship Training

Slide10

Updated policy memorandum from CMS (July 2018)QSO-17-30Previously S&C 17-30Facilities must have

water management plans and documentation, including:

Risk assessment for pathogens growth in the facility water system.

Water management program, testing protocols with ranges, and control measures.

ASHRAE industry standard and the CDC toolkit. Requirement for all Hospitals, Critical Access Hospitals, and Long-Term Care Facilities

CMS Legionella and Water Management

Slide11

CMS Legionella and Water Management

www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Policy-and-Memos-to-States-and-Regions-Items/Survey-And-Cert-Letter-17-30-.html

www.cdc.gov/legionella/wmp/toolkit/index.html

www.ashrae.org/technical-resources/bookstore/ansi-ashrae-standard-188-2015-legionellosis-risk-management-for-building-water-systems

Slide12

Monitor antibiotic use and resistance to understand trends and identify resistant threats

Surveillance

Slide13

CDC has added MRSA TAP reports in NHSN for acute care hospitalsAvailable as of April 2018Baseline MRSA LabID data from 2015MRSA TAP report includes:SIR (Standardized Infection Ratio) CAD (Cumulative Attributable Difference)

New TAP Report in NHSN

Slide14

Factsheets on select MDROsLaboratory protocolsSampling recommendationsBest practicesLaboratory safety for MDROs

www.cdc.gov/hai/settings/lab/lab_settings.html

CDC Resources for Laboratorians

Slide15

NJDOH is accepting Carbapenem-resistant Klebsiella spp. and

E. coli

isolates for Carbapenemase testing

ID, AST, mCIM

RT-PCR for: IMP, KPC, NDM, OXA-48, VIMRegular submission is encouragedResults sent electronicallyFedEx shipping and testing free

CRE Lab Surveillance Program

Slide16

Novel Resistance Lab SurveillanceIsolates accepted at the Northeast AR Laboratory:

Carbapenem-resistant

Acinetobacter

Third-generation cephalosporin-resistant

E. coli and

Klebsiella spp.Pan non-susceptible isolates (I or R)Isolates with other concerning resistance patterns

Prior notification is required

Regular submissions can be set-up

FedEx shipping and testing free

Slide17

Patients who report international healthcare exposure in the past 365 days are considered high-risk for CP-CRE colonizationThe AR Lab Network supports admission screening for these high-risk patientsRectal swab coordinated through NJDOHSwabs, FedEx shipping, and testing free

CRE Admission Screening

Slide18

Implement control measures to contain and prevent transmission of resistant threats

Response

Slide19

Candida auris is nationally notifiableClinical isolates onlyPassed by the Council of State and Territorial Epidemiologists in June 2018C. auris

and

Candida haemulonii

complex

are expected to be added with the next update of the Communicable Diseases Regulations (N.J.A.C. 8:57)Timeline TBDGuidance will be shared once timeline established

Candida auris Reporting

Slide20

Diversion of injectable medications can lead to viral or bacterial infections.NJDOH resources include:Template policiesTabletop exercise tool for healthcare facilities to work through scenarios of diversionPublic health reporting algorithm

Drug Diversion Conferences

(recent conference June 2018)

Drug Diversion Resources

Sources: Maki et al., JAMA 1991; Hellinger et al., Ann Intern Med 2012

www.oneandonlycampaign.org/partner/new-jersey

Slide21

CDC has identified possible transmission of Acinetobacter calcoaceticus-Acinetobacter baumannii (ACB) via

platelet transfusion

2 cases identified in other states

Please report any cases where patients developed

ACB sepsis within 24 hours of platelet transfusions to local health departmentPlease report any cases since January 2018 and onwardOrganisms include:

A. baumannii, A. pittii, A. nosocomialis, and A. seifertii

Call for Cases

Slide22

Build and maintain capacity for prevention, surveillance, and response across New Jersey

Infrastructure

Slide23

Resistance Testing in ELR

NJDOH is beginning to assess the antibiotic susceptibility testing data sent through electronic lab reporting (

ELR

)

Goal: Integrate resistance data into Communicable Disease Reporting Surveillance System (CDRSS)

Slide24

[Enter HM Slides on AUR Module]

Slide25

Thank you!Patricia M. Barrett, MSD

Antimicrobial Resistance Coordinator

📞

609-826-5964

📩

patricia.barrett@doh.nj.gov

Slide26

Maki D.G., Klein B.S., McCormick R.D. Nosocomial Pseudomonas pickettii bacteremias traced to narcotic tampering: a case for selective drug screening of health care personnel. JAMA. 1991;265(8):981–986. [

PubMed

]

Hellinger W.C.,

Bacalis L.P., Kay R.S. Health care-associated hepatitis C virus infections attributed to narcotic diversion. Ann Intern Med. 2012;156:477–482. [PubMed]

References